Hepatocellular carcinoma: Current management and future trends

Gastroenterology

Volumn 127, Issue 5 SUPPL., 2004, Pages

  Carr, Brian I ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DOXORUBICIN; FLUOROURACIL; TAMOXIFEN;

CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; SEX DIFFERENCE; SIDE EFFECT; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 7044239399     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.09.036     Document Type: Conference Paper

References (46)

1. B.I. Carr, D. Bartlett, J.W. Marsh Cancers of the liver V.T. DeVita S. Hellman S.A. Rosenberg Cancer principles and practice of oncology Edition 7 2004 Lippincott Philadelphia, PA
2. K. Okuda, T. Ohtsuki, H. Obata, M. Tomimatsu, N. Okazaki, H. Hasegawa, Y. Nakajima, K. Ohnishi Natural history of hepatocellular carcinoma and prognosis in relation to treatment Cancer 56 1985 918 928
3. S. Iwatsuki, T.E. Starzl, D.G. Sheahan, I. Yokoyama, A.J. Demetris, S. Todo, A.G. Tzakis, D.H. van Thiel, B. Carr, R. Selby Hepatic resection versus transplantation for hepatocellular carcinoma Ann Surg 214 1991 221 229
4. B.I. Carr Hepatic artery chemoembolization for advanced-stage HCC experience of 50 patients Hepatogastroenterology 49 2002 79 86
5. J. Bruix, M. Sherman, J.M. Llovet, M. Baugrand, R. Lencioni, A.K. Burroughs, E. Christensen, L. Pagliaro, M. Colombo, J. Rodes EASL Panel of Experts on HCC Clinical management of hepatocellular carcinoma conclusions of the Barcelona-2000 EASL Conference J Hepatol 35 2001 421 430
6. Y. Kurokawa, R. Matoba, I. Takemassa, H. Nagano, K. Dono, S. Nakamori, K. Umeshita, M. Sakon, N. Ueno, S. Oba, S. Ishii, K. Kato, M. Monden Molecular-based prediction of early recurrences in hepatocellular carcinoma J Hepatol 41 2004 284 291
7. R. Pichlmayr, A. Weimann, K.J. Oldhafer, H.J. Schlitt, G. Tusch, R. Raab Appraisal of transplantation for malignant tumors of the liver with special reference to early stage hepatocellular carcinoma Eur J Surg Oncol 24 1998 60 67
8. C. Camma, F. Schepis, A. Orlando, M. Albanese, L. Shahied, F. Trevisani, P. Andreone, A. Craxi, M. Cottone Transarterial chemoembolization for unresectable hepatocellular carcinoma meta-analysis of randomized controlled trials Radiology 224 2002 47 54
9. J.M. Llovet, J. Bruix Systemic review of randomized trials for unresectable hepatocellular carcinoma chemoembolization improves survival Hepatology 37 2003 429 442
10. J.M. Llovet, A. Burroughs, J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
11. W. Yeo, B. Zee, W.T. Leung, W.Y. Lau, T.S.K. Mok, H.T.M. Wong, J. Koh, S. Yu, A.T.C. Chan, P.J. Johnson A phase II study of doxorubicin (A) versus cisplatin (P)/interferon α-2b (I)/doxorubicin (A)/fluorouracil (F) combination chemotherapy (PIAF) for inoperable hepatocellular carcinoma (HCC) [abstr] Proc Am Soc Clin Oncol 23 2004 4026
12. J.M. Llovet, M.I. Real, X. Montana, R. Planas, S. Coll, J. Aponte, C. Ayuso, M. Sala, J. Muchart, R. Sola, J. Rodes, J. Bruix Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma a randomized controlled trial Lancet 359 2002 1734 1739
13. C.M. Lo, H. Ngan, W.K. Tso, C.L. Liu, C.M. Lam, R.T.P. Poon, S.T. Fan, J. Wong Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
14. W.Y. Lau, T.W. Leung, S.K. Ho, M. Chan, D. Machin, J. Lau, A.T. Chan, W. Yeo, T.S. Mok, S.C. Yu, N.W. Leung, P.J. Johnson Adjuvant intra-arterial iodine-131-labelled Lipiodol for resectable hepatocellular carcinoma a prospective randomised trial Lancet 353 1999 797 801
15. C.C. Wu, Y.Z. Ho, W.L. Ho, T.C. Wu, T.J. Liu, F.K. P'eng Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma a reappraisal Br J Surg 82 1995 122 126
16. J.W. Marsh, S.D. Finkelstein, A.J. Demetris, P.A. Swalsky, E. Sasatomi, A. Bandos, M. Subotin, I. Dvorchik Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival Liver Transpl 9 2003 664 671
17. S.D. Finkelstein, W. Marsh, A.J. Demetris, P.A. Swalsky, E. Sasatomi, A. Bonham, M. Subotin, I. Dvorchik Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma Hepatology 37 2003 871 879
18. J.W. Marsh, I. Dvorchik, M. Subotin, V. Ballan, J. Rakela, E.P. Popechitelev, V. Subbotin, A. Casavilla, B.I. Carr, J.J. Fung, S. Iwatsuki The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation a pilot study Hepatology 26 1997 444 450
19. S. Iwatsuki, I. Dvorchik, J.W. Marsh, J.R. Madariaga, B. Carr, J.J. Fung, T.E. Starzl Liver transplantation for hepatocellular carcinoma a proposal of a prognostic scoring system J Am Coll Surg 191 2000 389 394
20. K.S. Jeng, I.S. Sheen, Y.C. Wang, S.L. Gu, C.M. Chu, S.C. Shih, P.C. Wang, W.H. Chang, H.Y. Wang Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma a prospective study World J Gastroenterol 10 2004 643 648
21. R.T. Poon, K.K. Chung, S.T. Cheung, C.P. Lau, S.W. Tong, K.L. Leung, W.C. Yu, G.P. Tuszynski, S.T. Fan Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma Clin Cancer Res 10 2004 4150 4157
22. J. Cui, B.W. Dong, P. Liang, X.L. Yu, D.J. Yu Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection World J Gastroenterol 10 2004 1533 1536
23. J.W. Kim, Q. Ye, M. Forgues, Y. Chen, A. Budhu, J. Sime, L.J. Hofseth, R. Kaul, X.W. Wang Cancer-associated molecular signature in the tissue samples of patients with cirrhosis Hepatology 39 2004 518 527
24. S. Kar, B.I. Carr Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma Hepatology 21 1995 403 407
25. O.M. Ebied, M.P. Federle, B.I. Carr, K.M. Pealer, W. Li, N. Amesur, A. Zajko Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma Cancer 97 2003 1042 1050
26. 90yttrium microspheres (Therasphere) Psychooncology 13 2004 73 79
27. J. Steel, M. Carney, B.I. Carr, A. Baum The role of psychological factors in the progression of hepatocellular carcinoma Med Hypotheses 62 2004 86 94
28. Y.Z. Patt, M.M. Hassan, R.D. Lozano, L.M. Ellis, J.M. Peterson, K.A. Waugh Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide Am J Clin Oncol 23 2000 319 321
29. D. Dimitroulopoulos, D. Xinopoulos, K. Tsamakidis, A. Zisimopoulos, E. Andriotis, S. Markidou, D. Panagiotakis, C. Chrysohoou, A. Bazinis, E. Paraskevas The role of Sandostatin in treating patients with advanced hepatocellular carcinoma Hepatogastroenterology 49 2002 1245 1250
30. T. Zhang, S.S. Wang, L. Hong, X.L. Wang, Q.H. Qi Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo J Exp Clin Cancer Res 22 2003 61 68
31. J. Qian, S. Qin, Z. He Arsenic trioxide in the treatment of advanced primary liver and gallbladder cancer Zhonghua Zhong Liu Za Zhi 23 2001 487 489
32. 90yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma interim safety and survival data on 65 patients Liver Transpl 10 Suppl 1 2004 S107 S110
33. 90yttrium microspheres (Therasphere) treatment in 80 patients Proc Am Soc Clin Oncol 23 2004 4085 [abstr]
34. S. Ho, W.Y. Lau, T.W. Leung, P.J. Johnson Internal radiation therapy for patients with primary or metastatic hepatic cancer a review Cancer 83 1998 1894 1907
35. W.Y. Lau, W.T. Leung, S. Ho, N.W. Leung, M. Chan, J. Lin, C. Metreweli, P. Johnson, A.K. Li Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres a phase I and II study Br J Cancer 70 1994 994 999
36. W.Y. Lau, S. Ho, W.T. Leung, M. Chan, W.Y. Lee, P.J. Johnson What determines survival duration in hepatocellular carcinoma treated with intraarterial yttrium-90 microspheres? Hepatogastroenterology 48 2001 338 340
37. B.I. Carr, Z. Wang, M.A. Virgi, M. Piper Vitamin K (VK) inhibits hepatoma cell growth in vitro and in patients [abstr] Proc Am Assoc Cancer Res 37 1996 1485
38. Z. Wang, M. Wang, F. Finn, B.I. Carr The growth inhibitory effects of vitamins K and their actions on gene expression Hepatology 22 1995 876 882
39. B.I. Carr Suppression of DCP/Pivka-2 and alpha-fetoprotein levels in human hepatocellular carcinoma (HCC) by high doses of vitamin K1 (VK1) [abstr] Proc Am Assoc Cancer Res 24 1996 887
40. M. Otsuka, N. Kato, R.X. Shao, Y. Hoshida, H. Ijichi, Y. Koike, H. Taniguchi, M. Moriyama, Y. Shiratori, T. Kawabe, M. Omata Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation Hepatology 40 2004 243 251
41. S. Kar, M. Wang, C. Wilcox, B.I. Carr Antitumor and anticarcinogenic actions of Cpd 5 a new class of phosphatase inhibitor Carcinogenesis 24 2003 411 416
42. B.I. Carr, Z. Wang, S. Kar K vitamins, PTP antagonism and cell growth arrest J Cell Physiol 193 2002 263 274
43. S.W. Ham, B.I. Carr Cell division cycle (Cdc25) phosphatase inhibitors as antitumor agents Drug Design Reviews--Online 1 2004 123 132
44. A.S. Cheng, H.L. Chan, W.K. Leung, N. Wong, P.J. Johnson, J.J. Sung Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells Int J Oncol 23 2003 113 119
45. J. Cheng, H. Imanishi, W. Liu, H. Nakamura, T. Morisaki, K. Higashimo, T. Hada Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines Cancer Sci 95 2004 666 673
46. M.A. Kern, M.M. Schoneweiss, D. Sahi, M. Bahlo, A.M. Haugg, H.U. Kasper, H.P. Dienes, H. Kaferstein, K. Breuhahn, P. Schirmacher Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice Carcinogenesis 25 2004 1193 1199